|
|
800 Bradbury SE, Suite 217
Albuquerque, NM 87106 USA
phone:505-272-7023
fax:505-272-7112
|
|
| Symbol |
Private |
| Founded |
2004 |
| Employees |
|
|
|
| www.veralight.com
|
|
| Research Sector |
Medical Devices & Tech |
|
 |
| Summary Description |
| Developer of a noninvasive screening device for diabetes |
|
| Management |
| David VanAvermaete, CEO; John Maynard, Executive Vice President; Marwood Ediger, CTO; Mirasol Panlilio, VP of Marketing and Sales |
| |
|
|
| |
|
| Keywords |
| Diabetes, blood sugar, diabetic, metabolic, insulin, screening, type 2, advamed |
|
|
|
| Description |
|
VeraLight is a medical instrumentation company that was established in October 2004 as an independent spinout of InLight Solutions to focus on a comprehensive approach to noninvasive diabetes screening. |
|
| Products / Services |
VeraLight's lead product is a desk-top instrument, code-named Scout , that detects diabetes in a minute via fluorescent light emitted from an individual's forearm and does not require patient fasting. Scout is slated for market introduction in 2008, a prototype of the system was able to identify 29 percent more pre-diabetes and type 2 diabetes patients than the FPG test, according to a study presented at the 2006 Scientific Assembly of the American Academy of Family Physicians.
|
|
| Technology / Differentiation |
| Scout employs fluorescence spectroscopy to noninvasively measure advanced glycation endproducts (AGEs) in the skin of a subject's forearm. Skin AGEs are a well-known biomarker of diabetes, an excellent indicator of cumulative hyperglycemic exposure, and have been shown to predict the development of type 2 diabetes. |
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members